NDT Pharmaceuticals Income Statement
Last quarter (Q3 2025), NDT Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, NDT Pharmaceuticals's net income was $-9.22K. See NDT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.